Targeted therapies for lung cancer: how did the game begin?

Breathe (Sheff)

Oxford Centre for Respiratory Medicine and Oxford Respiratory Trials Unit, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Respiratory Medicine Laboratory, Nuffield Dept of Medicine, University Of Oxford, Old Road Campus, Oxford, UK.

Published: June 2016

Landmark studies on genetic alterations underlying NSCLC have led to tailored therapies http://ow.ly/4nq0Ps.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933615PMC
http://dx.doi.org/10.1183/20734735.006316DOI Listing

Publication Analysis

Top Keywords

targeted therapies
4
therapies lung
4
lung cancer
4
cancer game
4
game begin?
4
begin? landmark
4
landmark studies
4
studies genetic
4
genetic alterations
4
alterations underlying
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!